Literature DB >> 15746792

Metalloproteinases and their inhibitors are markers of plaque instability.

Paolo Sapienza1, Luca di Marzo, Valeria Borrelli, Antonio V Sterpetti, Andrea Mingoli, Silvia Cresti, Antonino Cavallaro.   

Abstract

BACKGROUND: Our aim was to investigate the release, activity, and expression of matrix metalloproteinases (MMPs)-1, -2, -3 and -9, and tissue inhibitors of metalloproteinases (TIMPs)-1 and -2 in patients undergoing carotid endarterectomy and to determine whether altered plasma levels of MMPs and TIMPs may be correlated with carotid instability.
METHODS: The carotid plaques of 53 consecutive patients who underwent carotid endarterectomy were classified histologically as stable or unstable. The release of MMPs and TIMPs was analyzed in the serum of patients with stable and unstable carotid plaques, and in 15 age-matched healthy volunteers. The production, activity, and expression of MMPs and TIMPs were determined by Western blotting, zymography, and reverse transcriptase polymerase chain reaction in the carotid specimens.
RESULTS: Twenty-nine (55%) patients had an unstable carotid plaque and 24 (45%) a stable plaque. Plasma levels of MMPs were higher in patients with unstable plaques compared to patients with stable plaques and healthy volunteers ( P < .001), whereas plasma levels of TIMPs were lower in patients with unstable plaques compared to patients with stable plaques and healthy volunteers ( P < .001). In the carotid specimens, we found increased activity, production, and expression of MMPs, and decreased activity, production and expression of TIMPs in unstable plaques compared to stable plaques ( P < .001). After endarterectomy, plasma levels of MMPs and TIMPs in patients with unstable and stable plaques returned to the values found in healthy volunteers.
CONCLUSIONS: Our study demonstrated that an imbalance exists between MMPs and TIMPs in unstable carotid plaques, which is reflected in the plasma levels of these markers. These data may help in selecting patients at high risk for cerebral events.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15746792     DOI: 10.1016/j.surg.2004.10.011

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  13 in total

1.  Relationship between matrix metalloproteinase-9 and common carotid artery intima media thickness.

Authors:  Maged Abdelnaseer; Nervana Elfayomi; Eman H Esmail; Manal M Kamal; Ahmed Hamdy; Rasha M Abdel Samie; Enji Elsawy
Journal:  Neurol Sci       Date:  2015-08-30       Impact factor: 3.307

2.  Different inflammatory cytokines release after open and endovascular reconstructions influences wound healing.

Authors:  Paolo Sapienza; Andrea Mingoli; Valeria Borrelli; Raffaele Grande; Antonio V Sterpetti; Daniele Biacchi; Ciro Ferrer; Paolo Rubino; Raffaele Serra; Elvira Tartaglia
Journal:  Int Wound J       Date:  2019-06-03       Impact factor: 3.315

3.  TIMP2 gene polymorphisms are associated with hypertension in patients with myocardial infarction.

Authors:  José Manuel Rodríguez-Pérez; Nancy Martínez-Rodríguez; Gilberto Vargas-Alarcón; Maite Vallejo; Irma Eloisa Monroy-Muñoz; Carlos Posadas-Romero; Eric Kimura-Hayama; Teresa Juárez-Cedillo; José Manuel Fragoso; Nonanzit Pérez-Hernández
Journal:  J Genet       Date:  2014-08       Impact factor: 1.166

4.  Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome.

Authors:  Valéria A Gomes; Carolina S Vieira; Anna L Jacob-Ferreira; Vanessa A Belo; Gustavo M Soares; Janaína B F Fernandes; Rui A Ferriani; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2011-03-25       Impact factor: 3.396

5.  Association of circulating matrix metalloproteinases with carotid artery characteristics: the Atherosclerosis Risk in Communities Carotid MRI Study.

Authors:  John W Gaubatz; Christie M Ballantyne; Bruce A Wasserman; Max He; Lloyd E Chambless; Eric Boerwinkle; Ron C Hoogeveen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-18       Impact factor: 8.311

6.  Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: the Framingham Offspring Study.

Authors:  Jose R Romero; Ramachandran S Vasan; Alexa S Beiser; Joseph F Polak; Emelia J Benjamin; Philip A Wolf; Sudha Seshadri
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 Nov-Dec       Impact factor: 2.136

7.  Local release of metalloproteinases and their inhibitors after a successful revascularisation procedure.

Authors:  Raffaele Grande; Gioia Brachini; Antonio V Sterpetti; Valeria Borrelli; Raffaele Serra; Francesco Pugliese; Giuseppe D'Ermo; Elvira Tartaglia; Paolo Rubino; Andrea Mingoli; Paolo Sapienza
Journal:  Int Wound J       Date:  2019-10-27       Impact factor: 3.315

8.  Increased levels of leukocyte-derived MMP-9 in patients with stable angina pectoris.

Authors:  Simon Jönsson; Anna Lundberg; Hanna Kälvegren; Ida Bergström; Aleksander Szymanowski; Lena Jonasson
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

9.  Perioperative time course of matrix metalloproteinase-9 (MMP-9), its tissue inhibitor TIMP-1 & S100B protein in carotid surgery.

Authors:  Bálint Nagy; Gábor Woth; Ákos Mérei; Lilla Nagy; János Lantos; Gábor Menyhei; Lajos Bogár; Diána Mühl
Journal:  Indian J Med Res       Date:  2016-02       Impact factor: 2.375

Review 10.  Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability.

Authors:  Wioletta Olejarz; Dominika Łacheta; Grażyna Kubiak-Tomaszewska
Journal:  Int J Mol Sci       Date:  2020-05-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.